Elevated levels of Dickkopf-related protein 3 in seminal plasma of prostate cancer patients

Journal of Translational Medicine

Volumn 9, Issue 1, 2011, Pages

  Zenzmaier, Christoph ^a   Heitz, Martin ^a   Klocker, Helmut ^b   Buck, Marion ^c   Gardiner, Robert A ^c   Berger, Peter ^a  

^a ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Dickkopf 3; Dkk 3; Iema; Prostate specific antigen; Seminal fluid

Indexed keywords

DICKKOPF 3 PROTEIN; GLYCOPROTEIN; PROSTATE SPECIFIC ANTIGEN; UNCLASSIFIED DRUG; DKK3 PROTEIN, HUMAN; SIGNAL PEPTIDE;

ADULT; ARTICLE; CANCER PATIENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIGITAL RECTAL EXAMINATION; DISEASE MARKER; HUMAN; IMMUNOFLUORESCENCE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PROSTATE BIOPSY; PROSTATE CANCER; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SEMINAL PLASMA; TRANSRECTAL ULTRASONOGRAPHY; AGED; BIOASSAY; COHORT ANALYSIS; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROSTATE TUMOR; RECEIVER OPERATING CHARACTERISTIC; SPERM; STATISTICAL MODEL;

AGED; BIOLOGICAL ASSAY; COHORT STUDIES; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROSTATIC NEOPLASMS; ROC CURVE; SEMEN;

EID: 80755159355     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-9-193     Document Type: Article

References (25)

1. Krupnik VE, Sharp JD, Jiang C, Robison K, Chickering TW, Amaravadi L, Brown DE, Guyot D, Mays G, Leiby K, et al. Functional and structural diversity of the human Dickkopf gene family. Gene 1999, 238(2):301-313. 10.1016/S0378-1119(99)00365-0, 10570958.
2. Niehrs C. Function and biological roles of the Dickkopf family of Wnt modulators. Oncogene 2006, 25(57):7469-7481. 10.1038/sj.onc.1210054, 17143291.
3. Wu W, Glinka A, Delius H, Niehrs C. Mutual antagonism between dickkopf1 and dickkopf2 regulates Wnt/beta-catenin signalling. Curr Biol 2000, 10(24):1611-1614. 10.1016/S0960-9822(00)00868-X, 11137016.
4. Mao B, Wu W, Li Y, Hoppe D, Stannek P, Glinka A, Niehrs C. LDL-receptor-related protein 6 is a receptor for Dickkopf proteins. Nature 2001, 411(6835):321-325. 10.1038/35077108, 11357136.
5. Hsieh SY, Hsieh PS, Chiu CT, Chen WY. Dickkopf-3/REIC functions as a suppressor gene of tumor growth. Oncogene 2004, 23(57):9183-9189.
6. Tsuji T, Miyazaki M, Sakaguchi M, Inoue Y, Namba M. A REIC gene shows down-regulation in human immortalized cells and human tumor-derived cell lines. Biochem Biophys Res Commun 2000, 268(1):20-24. 10.1006/bbrc.1999.2067, 10652205.
7. Tsuji T, Nozaki I, Miyazaki M, Sakaguchi M, Pu H, Hamazaki Y, Iijima O, Namba M. Antiproliferative activity of REIC/Dkk-3 and its significant down-regulation in non-small-cell lung carcinomas. Biochem Biophys Res Commun 2001, 289(1):257-263. 10.1006/bbrc.2001.5972, 11708809.
8. Nozaki I, Tsuji T, Iijima O, Ohmura Y, Andou A, Miyazaki M, Shimizu N, Namba M. Reduced expression of REIC/Dkk-3 gene in non-small cell lung cancer. Int J Oncol 2001, 19(1):117-121.
9. Kurose K, Sakaguchi M, Nasu Y, Ebara S, Kaku H, Kariyama R, Arao Y, Miyazaki M, Tsushima T, Namba M, et al. Decreased expression of REIC/Dkk-3 in human renal clear cell carcinoma. J Urol 2004, 171(3):1314-1318. 10.1097/01.ju.0000101047.64379.d4, 14767340.
10. Kobayashi K, Ouchida M, Tsuji T, Hanafusa H, Miyazaki M, Namba M, Shimizu N, Shimizu K. Reduced expression of the REIC/Dkk-3 gene by promoter-hypermethylation in human tumor cells. Gene 2002, 282(1-2):151-158. 10.1016/S0378-1119(01)00838-1, 11814687.
11. Lodygin D, Epanchintsev A, Menssen A, Diebold J, Hermeking H. Functional epigenomics identifies genes frequently silenced in prostate cancer. Cancer Res 2005, 65(10):4218-4227. 10.1158/0008-5472.CAN-04-4407, 15899813.
12. Untergasser G, Koch HB, Menssen A, Hermeking H. Characterization of epithelial senescence by serial analysis of gene expression: identification of genes potentially involved in prostate cancer. Cancer Res 2002, 62(21):6255-6262.
13. Zenzmaier C, Untergasser G, Hermann M, Dirnhofer S, Sampson N, Berger P. Dysregulation of Dkk-3 expression in benign and malignant prostatic tissue. Prostate 2008, 68(5):540-547. 10.1002/pros.20711, 18247400.
14. Sampson N, Untergasser G, Plas E, Berger P. The ageing male reproductive tract. J Pathol 2007, 211(2):206-218. 10.1002/path.2077, 17200938.
15. Zenzmaier C, Marksteiner J, Kiefer A, Berger P, Humpel C. Dkk-3 is elevated in CSF and plasma of Alzheimer's disease patients. J Neurochem 2009, 110(2):653-661. 10.1111/j.1471-4159.2009.06158.x, 19457090.
16. Clements JA, Merritt T, Devoss K, Swanson C, Hamlyn L, Scells B, Rohde P, Lavin MF, Yaxley J, Gardiner RA. Inactive free: total prostate specific antigen ratios in ejaculate from men with suspected and known prostate cancer, compared with young control men. BJU Int 2000, 86(4):453-458. 10.1046/j.1464-410X.2000.00835.x, 10971271.
17. Gardiner RA, Samaratunga ML, Gwynne RA, Clague A, Seymour GJ, Lavin MF. Abnormal prostatic cells in ejaculates from men with prostatic cancer--a preliminary report. Br J Urol 1996, 78(3):414-418. 10.1046/j.1464-410X.1996.00089.x, 8881953.
18. Zenzmaier C, Sklepos L, Berger P. Increase of Dkk-3 blood plasma levels in the elderly. Exp Gerontol 2008, 43(9):867-870. 10.1016/j.exger.2008.05.012, 18573329.
19. Berger P, Panmoung W, Khaschabi D, Mayregger B, Wick G. Antigenic features of human follicle stimulating hormone delineated by monoclonal antibodies and construction of an immunoradiomometric assay. Endocrinology 1988, 123(5):2351-2359. 10.1210/endo-123-5-2351, 2458911.
20. Kawano Y, Kitaoka M, Hamada Y, Walker MM, Waxman J, Kypta RM. Regulation of prostate cell growth and morphogenesis by Dickkopf-3. Oncogene 2006, 25(49):6528-6537. 10.1038/sj.onc.1209661, 16751809.
21. Schalken JA. Molecular and cellular prostate biology: origin of prostate-specific antigen expression and implications for benign prostatic hyperplasia. BJU Int 2004, 93(Suppl 1):5-9.
22. Clarke RA, Schirra HJ, Catto JW, Lavin MF, Gardiner RA. Markers for detection of prostate cancer. Cancers 2010, 2:1125-1154.
23. Makarov DV, Loeb S, Getzenberg RH, Partin AW. Biomarkers for prostate cancer. Annu Rev Med 2009, 60:139-151. 10.1146/annurev.med.60.042307.110714, 18947298.
24. Sardana G, Dowell B, Diamandis EP. Emerging biomarkers for the diagnosis and prognosis of prostate cancer. Clin Chem 2008, 54(12):1951-1960. 10.1373/clinchem.2008.110668, 18927246.
25. Landers KA, Burger MJ, Tebay MA, Purdie DM, Scells B, Samaratunga H, Lavin MF, Gardiner RA. Use of multiple biomarkers for a molecular diagnosis of prostate cancer. Int J Cancer 2005, 114(6):950-956. 10.1002/ijc.20760, 15609297.